Arlington Partners LLC Zoetis Inc. Transaction History

Arlington Partners LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$151.44 - $200.09 $258,356 - $341,353	-1,706 Reduced 80.02%	426 $84,000
Q3 2023 Oct 24, 2023	BUY	$167.14 - $192.77 $34,430 - $39,710	206 Added 10.7%	2,132 $370,000
Q2 2023 Jul 26, 2023	BUY	$160.94 - $186.23 $183,471 - $212,302	1,140 Added 145.04%	1,926 $331,000
Q1 2023 Apr 26, 2023	BUY	$145.48 - $175.02 $65,902 - $79,284	453 Added 136.04%	786 $130,000
Q3 2022 Oct 28, 2022	SELL	$148.29 - $182.55 $50,418 - $62,067	-340 Reduced 50.52%	333 $49,000
Q2 2022 Jul 25, 2022	BUY	$155.97 - $200.09 $53,029 - $68,030	340 Added 102.1%	673 $116,000
Q1 2022 Apr 14, 2022	SELL	$181.39 - $234.03 $5,078 - $6,552	-28 Reduced 7.76%	333 $63,000
Q4 2021 Jan 18, 2022	BUY	$193.69 - $247.03 $32,539 - $41,501	168 Added 87.05%	361 $88,000
Q4 2020 Jan 13, 2021	BUY	$157.07 - $174.35 $30,314 - $33,649	193 New	193 $32,000
Q2 2020 Jul 13, 2020	SELL	$111.92 - $142.53 $5,707 - $7,269	-51 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$92.66 - $144.94 $4,725 - $7,391	51 New	51 $6,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.